Skip to main content

Peer Review reports

From: Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

Original Submission
29 Sep 2022 Submitted Original manuscript
29 Nov 2022 Author responded Author comments - Fulya Cosan
Resubmission - Version 2
29 Nov 2022 Submitted Manuscript version 2
8 Jan 2023 Reviewed Reviewer Report
19 Jan 2023 Reviewed Reviewer Report - Catherine Hofstetter
10 Feb 2023 Reviewed Reviewer Report
11 Mar 2023 Author responded Author comments - Fulya Cosan
Resubmission - Version 3
11 Mar 2023 Submitted Manuscript version 3
12 Apr 2023 Reviewed Reviewer Report
17 Apr 2023 Reviewed Reviewer Report
28 Apr 2023 Author responded Author comments - Fulya Cosan
Resubmission - Version 4
28 Apr 2023 Submitted Manuscript version 4
2 May 2023 Reviewed Reviewer Report
16 May 2023 Reviewed Reviewer Report
20 May 2023 Author responded Author comments - Fulya Cosan
Resubmission - Version 5
20 May 2023 Submitted Manuscript version 5
30 May 2023 Author responded Author comments - Fulya Cosan
Resubmission - Version 6
30 May 2023 Submitted Manuscript version 6
11 Jun 2023 Author responded Author comments - Fulya Cosan
Resubmission - Version 7
11 Jun 2023 Submitted Manuscript version 7
Publishing
20 Jun 2023 Editorially accepted
19 Jul 2023 Article published 10.1186/s41927-023-00342-x

You can find further information about peer review here.

Back to article page